Beilstein J. Org. Chem. 2011, 7, 396–403.
2-Hexyl-1-(4-chlorophenyl)buta-2,3-dien-1-one (2d)
2-Pentyl-1-(3-thienyl)buta-2,3-dien-1-one (2g)
The reaction of 1,10-phenanthroline (5.5 mg, 0.03 mmol), 2,2'- The reaction of 1,10-phenanthroline (5.5 mg, 0.03 mmol), 2,2'-
bipyridine (4.8 mg, 0.03 mmol), CuCl (6.0 mg, 0.06 mmol), bipyridine (4.8 mg, 0.03 mmol), CuCl (5.9 mg, 0.06 mmol),
K2CO3 (20.9 mg, 0.15 mmol), dry toluene (1.5 mL), K2CO3 (20.9 mg, 0.15 mmol), dry toluene (1.5 mL), DBAD
DBAD (13.8 mg, 0.06 mmol), and 2-hexyl-1-(4- (13.7 mg, 0.06 mmol), and 2-pentyl-1-(3-thienyl)buta-2,3-dien-
chlorophenyl)buta-2,3-dien-1-ol (79.6 mg, 0.3 mmol)/dry 1-ol (66.4 mg, 0.3 mmol)/dry toluene (1.5 mL) afforded 2g
toluene (1.5 mL) afforded 2d (62.0 mg, 78%): liquid; 1H NMR (48.3 mg, 73%) (eluent: petroleum ether/diethyl ether = 50:1):
(300 MHz, CDCl3) δ 7.70 (d, J = 8.4 Hz, 2H), 7.35 (d, J = 8.4 liquid; 1H NMR (300 MHz, CDCl3) δ 8.07 (d, J = 1.8 Hz, 1H)
Hz, 2H), 5.06 (t, J = 2.6 Hz, 2H), 2.43–2.32 (m, 2H), 1.55–1.42 7.53 (d, J = 4.8 Hz, 1H), 7.25 (dd, J1 = 4.8 Hz, J2 = 3.3 Hz,
(m, 2H), 1.43–1.18 (m, 6H), 0.88 (t, J = 6.3 Hz, 3H) ppm; 1H), 5.16 (d, J = 2.7 Hz, 2H), 2.41–2.32 (m, 2H), 1.56–1.42 (m,
13C NMR (75.4 MHz, CDCl3) δ 217.0, 193.6, 138.2, 136.6, 2H), 1.42–1.24 (m, 4H), 0.90 (t, J = 6.6 Hz, 3H) ppm;
130.4, 128.1, 106.9, 79.6, 31.6, 28.9, 27.7, 22.5, 14.0 ppm; MS 13C NMR (75.4 MHz, CDCl3) δ 216.0, 187.1, 141.5, 132.2,
(m/z) 264 (M+ (37Cl), 0.76), 262 (M+ (35Cl), 2.08), 139 (100); 128.2, 125.1, 107.6, 79.6, 31.4, 27.9, 27.5, 22.4, 14.0 ppm; MS
IR (neat) 2927, 2857, 1931, 1654, 1590, 1460, 1397, 1274, (m/z) 220 (M+, 3.02), 111 (100); IR (neat) 2956, 2927, 2861,
1091 cm−1; HRMS-EI (m/z) calcd for C16H19O35Cl+ [M+]: 1933, 1641, 1511, 1460, 1411, 1260, 1082 cm−1; HRMS-EI
262.1124; found: 262.1130.
(m/z) calcd for C13H16OS+ [M+]: 220.0922; found: 220.0922.
2-Hexyl-1-(4'-nitrophenyl)buta-2,3-dien-1-one (2e)
2-Methyl-1-(1-naphthyl)buta-2,3-dien-1-one (2h)
The reaction of 1,10-phenanthroline (5.5 mg, 0.03 mmol), 2,2'- The reaction of 1,10-phenanthroline (5.5 mg, 0.03 mmol), 2,2'-
bipyridine (4.7 mg, 0.03 mmol), CuCl (5.9 mg, 0.06 mmol), bipyridine (4.8 mg, 0.03 mmol), CuCl (6.2 mg, 0.06 mmol),
K2CO3 (20.8 mg, 0.15 mmol), dry toluene (1.5 mL), DBAD K2CO3 (21.4 mg, 0.15 mmol), dry toluene (1.5 mL), DBAD
(13.9 mg, 0.06 mmol), and 2-hexyl-1-(4-nitrophenyl)buta-2,3- (13.5 mg, 0.06 mmol), and 2-methyl-1-naphthylbuta-2,3-dien-1-
dien-1-ol (82.7 mg, 0.3 mmol)/dry toluene (1.5 mL) afforded 2e ol (63.6 mg, 0.3 mmol)/dry toluene (1.5 mL) afforded 2h
(51.4 mg, 63%) (eluent: petroleum ether/diethyl ether = 20:1): (47.2 mg, 74%, an unknown substance could not be separated
liquid; 1H NMR (300 MHz, CDCl3) δ 8.24 (d, J = 8.7 Hz, 2H), via column chromatography and the purity of 2h is 95%, which
7.84 (d, J = 8.7 Hz, 2H), 5.12 (t, J = 2.9 Hz, 2H), 2.44–2.33 (m, was determined by 1H NMR with mesitylene as the internal
2H), 1.57–1.44 (m, 2H), 1.44–1.20 (m, 6H), 0.89 (t, J = 6.5 Hz, standard): liquid; 1H NMR (300 MHz, CDCl3) δ 8.11–8.03 (m,
3H) ppm; 13C NMR (75.4 MHz, CDCl3) δ 218.0, 193.4, 149.4, 1H), 7.95–7.81 (m, 2H), 7.61–7.39 (m, 4H), 4.80 (q, J = 2.8 Hz,
143.6, 129.7, 123.1, 107.6, 80.4, 31.5, 28.8, 27.7, 27.3, 22.5, 2H), 2.11 (t, J = 2.7 Hz, 3H) ppm; 13C NMR (75.4 MHz,
14.0 ppm; MS (m/z) 273 (M+, 2.56), 150 (100); IR (neat) 2927, CDCl3) δ 218.6, 197.5, 136.8, 133.5, 130.6, 130.4, 128.2,
2857, 1930, 1660, 1602, 1526, 1461, 1349, 1272, 1104, 126.9, 126.5, 126.1, 125.3, 123.9, 104.8, 78.2, 13.8 ppm; MS
1011 cm−1; HRMS-EI (m/z) calcd for C16H19NO3+ [M+]: (m/z) 208 (M+, 63.16), 155 (100); IR (neat) 3059, 1957, 1930,
273.1365; found: 273.1367.
1650, 1508, 1285, 1251, 1204, 1155, 1080, 1059 cm−1; HRMS-
EI (m/z) calcd for C15H12O [M+]: 208.0888; found: 208.0887.
2-Hexyl-1-(3-furanyl)buta-2,3-dien-1-one (2f)
The reaction of 1,10-phenanthroline (5.4 mg, 0.03 mmol), 2,2'- 2-Allyl-1-phenylbuta-2,3-dien-1-one (2i)
bipyridine (4.8 mg, 0.03 mmol), CuCl (6.2 mg, 0.06 mmol), The reaction of 1,10-phenanthroline (5.4 mg, 0.03 mmol), 2,2'-
K2CO3 (21.3 mg, 0.15 mmol), dry toluene (1.5 mL), DBAD bipyridine (4.6 mg, 0.03 mmol), CuCl (6.1 mg, 0.06 mmol),
(13.6 mg, 0.06 mmol), and 2-hexyl-1-(3-furanyl)buta-2,3-dien- K2CO3 (21.5 mg, 0.15 mmol), dry toluene (1.5 mL), DBAD
1-ol (66.2 mg, 0.3 mmol)/dry toluene (1.5 mL) afforded (13.7 mg, 0.06 mmol), and 2-allyl-1-phenylbuta-2,3-dien-1-ol
2f (40.4 mg, 61%): liquid; 1H NMR (300 MHz, CDCl3) δ 8.10 (55.1 mg, 0.3 mmol)/dry toluene (1.5 mL) afforded 2i (41.1 mg,
(s, 1H), 7.37 (s, 1H), 6.81 (d, J = 1.2 Hz, 1H), 5.21 (t, J = 75%) (eluent: petroleum ether/diethyl ether = 40:1): liquid;
2.9 Hz, 2H), 2.39–2.27 (m, 2 H), 1.52–1.38 (m, 2H), 1.38–1.18 1H NMR (300 MHz, CDCl3) δ 7.78 (d, J = 7.8 Hz, 2H), 7.50 (t,
(m, 6H), 0.87 (t, J = 6.5 Hz, 3H) ppm; 13C NMR (75.4 MHz, J = 7.2 Hz, 1H), 7.39 (t, J = 7.5 Hz, 2H), 5.98–5.82 (m, 1H),
CDCl3) δ 215.8, 186.4, 147.4, 143.0, 126.7, 110.0, 108.1, 5.22–5.04 (m, 4H), 3.20–3.14 (m, 2H) ppm; 13C NMR
80.0, 31.6, 28.9, 27.8, 27.6, 22.6, 14.1 ppm; MS (m/z) 218 (M+, (75.4 MHz, CDCl3) δ 217.2, 194.1, 138.0, 134.9, 132.1, 129.0,
3.49), 95 (100); IR (neat) 2956, 2928, 2857, 1933, 1724, 127.8, 116.4, 105.3, 79.8, 32.5 ppm; MS (m/z) 184 (M+, 2.53),
1645, 1561, 1509, 1458, 1379, 1311, 1163, 1077, 1009 cm−1; 105 (100); IR (neat) 3081, 3062, 2982, 1956, 1931, 1651, 1598,
HRMS-EI (m/z) calcd for C14H18O2+ [M+]: 218.1307; found: 1578, 1447, 1422, 1316, 1272 cm−1; HRMS-EI (m/z) calcd for
218.1305.
C13H12O [M+]: 184.0888; found: 184.0889.
401